The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer
Open accessAbstract
Fully functional, tumor-specific, SLAMF7-expressing cytotoxic CD4 T cells directly mediate immunity against human cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
DeepLabCut: markerless pose estimation of user-defined body parts with deep learning
Mathis, A., Mamidanna, P., Cury, K. M., Abe, T., Murthy, V. N., Mathis, M. W., & Bethge, M. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0209-y · Cited by 5,187
Self-citationThe immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981
The Gene Ontology Resource: 20 years and still GOing strong
The Gene Ontology Consortium (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1055 · Cited by 4,747
Vignali, D. A. A., Collison, L. W., & Workman, C. J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2343 · Cited by 3,463
An immunogenic personal neoantigen vaccine for patients with melanoma
Ott, P. A., Hu, Z., Keskin, D. B., Shukla, S. A., Sun, J., Bozym, D. J., Zhang, W., Luoma, A., Giobbie-Hurder, A., Peter, L., et al. (2017) · Nature · doi:10.1038/nature22991 · Cited by 2,936
Puram, S. V., Tirosh, I., Parikh, A. S., Patel, A. P., Yizhak, K., Gillespie, S., Rodman, C., Luo, C. L., Mroz, E. A., Emerick, K. S., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.044 · Cited by 2,557
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing
Zheng, C., Zheng, L., Yoo, J.-K., Guo, H., Zhang, Y., Guo, X., Kang, B., Hu, R., Huang, J. Y., Zhang, Q., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.035 · Cited by 2,152
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
Sade-Feldman, M., Yizhak, K., Bjorgaard, S. L., Ray, J. P., de Boer, C. G., Jenkins, R. W., Lieb, D. J., Chen, J. H., Frederick, D. T., Barzily-Rokni, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.038 · Cited by 2,053
Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment
Azizi, E., Carr, A. J., Plitas, G., Cornish, A. E., Konopacki, C., Prabhakaran, S., Nainys, J., Wu, K., Kiseliovas, V., Setty, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.05.060 · Cited by 1,976
Böttcher, J. P., Bonavita, E., Chakravarty, P., Blees, H., Cabeza-Cabrerizo, M., Sammicheli, S., Rogers, N. C., Sahai, E., Zelenay, S., & Reis e Sousa, C. (2018) · Cell · doi:10.1016/j.cell.2018.01.004 · Cited by 1,857
Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer
Tran, E., Turcotte, S., Gros, A., Robbins, P. F., Lu, Y.-C., Dudley, M. E., Wunderlich, J. R., Somerville, R. P., Hogan, K., Hinrichs, C. S., et al. (2014) · Science · doi:10.1126/science.1251102 · Cited by 1,718
Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin
Intlekofer, A. M., Takemoto, N., Wherry, E. J., Longworth, S. A., Northrup, J. T., Palanivel, V. R., Mullen, A. C., Gasink, C. R., Kaech, S. M., Miller, J. D., et al. (2005) · Nature Immunology · doi:10.1038/ni1268 · Cited by 1,266
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Kreiter, S., Vormehr, M., van de Roemer, N., Diken, M., Löwer, M., Diekmann, J., Boegel, S., Schrörs, B., Vascotto, F., Castle, J. C., et al. (2015) · Nature · doi:10.1038/nature14426 · Cited by 1,243
Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1
Hunder, N. N., Wallen, H., Cao, J., Hendricks, D. W., Reilly, J. Z., Rodmyre, R., Jungbluth, A., Gnjatic, S., Thompson, J. A., & Yee, C. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800251 · Cited by 911
Quezada, S. A., Simpson, T. R., Peggs, K. S., Merghoub, T., Vider, J., Fan, X., Blasberg, R., Yagita, H., Muranski, P., Antony, P. A., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091918 · Cited by 898
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
Tian, L., Goldstein, A., Wang, H., Ching Lo, H., Sun Kim, I., Welte, T., Sheng, K., Dobrolecki, L. E., Zhang, X., Putluri, N., et al. (2017) · Nature · doi:10.1038/nature21724 · Cited by 841
Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer
Oh, D. Y., Kwek, S. S., Raju, S. S., Li, T., McCarthy, E., Chow, E., Aran, D., Ilano, A., Pai, C.-C. S., Rancan, C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.017 · Cited by 734
Immunogenicity of somatic mutations in human gastrointestinal cancers
Tran, E., Ahmadzadeh, M., Lu, Y.-C., Gros, A., Turcotte, S., Robbins, P. F., Gartner, J. J., Zheng, Z., Li, Y. F., Ray, S., et al. (2015) · Science · doi:10.1126/science.aad1253 · Cited by 729
Linnemann, C., van Buuren, M. M., Bies, L., Verdegaal, E. M. E., Schotte, R., Calis, J. J. A., Behjati, S., Velds, A., Hilkmann, H., Atmioui, D. E., et al. (2015) · Nature Medicine · doi:10.1038/nm.3773 · Cited by 679
The urgent need to recover MHC class I in cancers for effective immunotherapy
Garrido, F., Aptsiauri, N., Doorduijn, E. M., Garcia Lora, A. M., & van Hall, T. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.12.007 · Cited by 585
Rodig, S. J., Gusenleitner, D., Jackson, D. G., Gjini, E., Giobbie-Hurder, A., Jin, C., Chang, H., Lovitch, S. B., Horak, C., Weber, J. S., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar3342 · Cited by 579
Characterization of CD4+ CTLs Ex Vivo
Appay, V., Zaunders, J. J., Papagno, L., Sutton, J., Jaramillo, A., Waters, A., Easterbrook, P., Grey, P., Smith, D., McMichael, A. J., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5954 · Cited by 545
Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs
Cruz-Guilloty, F., Pipkin, M. E., Djuretic, I. M., Levanon, D., Lotem, J., Lichtenheld, M. G., Groner, Y., & Rao, A. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081242 · Cited by 520
Biological Consequences of MHC-II Expression by Tumor Cells in Cancer
Axelrod, M. L., Cook, R. S., Johnson, D. B., & Balko, J. M. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3200 · Cited by 490
Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma
Xie, Y., Akpinarli, A., Maris, C., Hipkiss, E. L., Lane, M., Kwon, E.-K. M., Muranski, P., Restifo, N. P., & Antony, P. A. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091921 · Cited by 457
van Leeuwen, E. M. M., Remmerswaal, E. B. M., Vossen, M. T. M., Rowshani, A. T., Wertheim-van Dillen, P. M. E., van Lier, R. A. W., & ten Berge, I. J. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.1834 · Cited by 368
Heterogeneity of CD4+ memory T cells: Functional modules for tailored immunity
Sallusto, F., & Lanzavecchia, A. (2009) · European Journal of Immunology · doi:10.1002/eji.200939722 · Cited by 348
Weiskopf, D., Bangs, D. J., Sidney, J., Kolla, R. V., De Silva, A. D., de Silva, A. M., Crotty, S., Peters, B., & Sette, A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505956112 · Cited by 303
Reis, B. S., Rogoz, A., Costa-Pinto, F. A., Taniuchi, I., & Mucida, D. (2013) · Nature Immunology · doi:10.1038/ni.2518 · Cited by 279
Lu, Y.-C., Parker, L. L., Lu, T., Zheng, Z., Toomey, M. A., White, D. E., Yao, X., Li, Y. F., Robbins, P. F., Feldman, S. A., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.5463 · Cited by 279
Precursors of human CD4 + cytotoxic T lymphocytes identified by single-cell transcriptome analysis
Patil, V. S., Madrigal, A., Schmiedel, B. J., Clarke, J., O’Rourke, P., de Silva, A. D., Harris, E., Peters, B., Seumois, G., Weiskopf, D., et al. (2018) · Science Immunology · doi:10.1126/sciimmunol.aan8664 · Cited by 262
Śledzińska, A., Vila de Mucha, M., Bergerhoff, K., Hotblack, A., Demane, D. F., Ghorani, E., Akarca, A. U., Marzolini, M. A. V., Solomon, I., Vargas, F. A., et al. (2020) · Immunity · doi:10.1016/j.immuni.2019.12.007 · Cited by 228
CRTAM determines the CD4+ cytotoxic T lymphocyte lineage
Takeuchi, A., Badr, M. E. S. G., Miyauchi, K., Ishihara, C., Onishi, R., Guo, Z., Sasaki, Y., Ike, H., Takumi, A., Tsuji, N. M., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20150519 · Cited by 210
CD4 and CD8 binding to MHC molecules primarily acts to enhance Lck delivery
Artyomov, M. N., Lis, M., Devadas, S., Davis, M. M., & Chakraborty, A. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010568107 · Cited by 207
Skin-resident memory CD4+ T cells enhance protection against Leishmania major infection
Glennie, N. D., Yeramilli, V. A., Beiting, D. P., Volk, S. W., Weaver, C. T., & Scott, P. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20142101 · Cited by 204
Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis
Maehara, T., Kaneko, N., Perugino, C. A., Mattoo, H., Kers, Allard-Chamard, H., Mahajan, V. S., Liu, H., Murphy, S. J. H., Ghebremichael, M., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci131700 · Cited by 192
Wiedemann, A., Depoil, D., Faroudi, M., & Valitutti, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600651103 · Cited by 183
Bobisse, S., Genolet, R., Roberti, A., Tanyi, J. L., Racle, J., Stevenson, B. J., Iseli, C., Michel, A., Bitoux, M. L., Guillaume, P., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03301-0 · Cited by 176
Self-citationTargeting the MHC Class II antigen presentation pathway in cancer immunotherapy
Thibodeau, J., Bourgeois-Daigneault, M.-C., & Lapointe, R. (2012) · OncoImmunology · doi:10.4161/onci.21205 · Cited by 164
Hirschhorn-Cymerman, D., Budhu, S., Kitano, S., Liu, C., Zhao, F., Zhong, H., Lesokhin, A. M., Avogadri-Connors, F., Yuan, J., Li, Y., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120532 · Cited by 159
Qui, H. Z., Hagymasi, A. T., Bandyopadhyay, S., St. Rose, M.-C., Ramanarasimhaiah, R., Ménoret, A., Mittler, R. S., Gordon, S. M., Reiner, S. L., Vella, A. T., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101244 · Cited by 158
CD4+ cytolytic T cell clone confers protection against murine malaria.
Tsuji, M., Romero, P. J., Nussenzweig, R. S., & Zavala, F. P. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.5.1353 · Cited by 146
Self-citationKitano, S., Tsuji, T., Liu, C., Hirschhorn-Cymerman, D., Kyi, C., Mu, Z., Allison, J. P., Gnjatic, S., Yuan, J. D., & Wolchok, J. D. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0068 · Cited by 136
The physiological role of cytotoxic CD4+ T-cells: the holy grail?
Appay, V. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02605.x · Cited by 127
Della‐Torre, E., Cassione, E. B., Sciorati, C., Ruggiero, E., Lanzillotta, M., Bonfiglio, S., Mattoo, H., Perugino, C. A., Bozzolo, E. P., Rovati, L., et al. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40469 · Cited by 116
Lancki, D. W., Hsieh, C., & Fitch, F. W. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.9.3242 · Cited by 107
Duftner, C., Goldberger, C., Falkenbach, A., Würzner, R., Falkensammer, B., Pfeiffer, K. P., Märker‐Hermann, E., & Schirmer, M. (2003) · Arthritis Research & Therapy · doi:10.1186/ar793 · Cited by 103
CS1 (SLAMF7, CD319) is an effective immunotherapeutic target for multiple myeloma.
Malaer, J. D., & Mathew, P. A. (2017) · PubMed · Cited by 100
Cytotoxic CD4+ T Cells Drive Multiple Sclerosis Progression
Peeters, L. M., Vanheusden, M., Somers, V. A., Wijmeersch, B. V., Stinissen, P., Broux, B., & Hellings, N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01160 · Cited by 99
Guo, H., Cruz‐Munoz, M., Wu, N., Robbins, M. D. H., & Veillette, A. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01107-14 · Cited by 88
Serroukh, Y. I. M., Gu‐Trantien, C., Kashani, B. H., Defrance, M., Manh, T. V., Azouz, A., Detavernier, A., Hoyois, A., Das, J., Bizet, M., et al. (2018) · eLife · doi:10.7554/elife.30496 · Cited by 87
Akhmetzyanova, I., Zelinskyy, G., Littwitz-Salomon, E., Малышкина, А. И., Dietze, K. K., Streeck, H., Brandau, S., & Dittmer, U. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403039 · Cited by 86
Cytomegalovirus-Specific CD4 T Cells Are Cytolytic and Mediate Vaccine Protection
Verma, S., Weiskopf, D., Gupta, A., McDonald, B., Peters, B., Sette, A., & Benedict, C. A. (2015) · Journal of Virology · doi:10.1128/jvi.02123-15 · Cited by 74
The Transcription Factor Hobit Identifies Human Cytotoxic CD4+ T Cells
Oja, A. E., Braga, F. A. V., Remmerswaal, E. B. M., Kragten, N. A. M., Hertoghs, K. M. L., Zuo, J., Moss, P. A. H., van Lier, R. A. W., van Gisbergen, K. P. J. M., & Hombrink, P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00325 · Cited by 73
The Differentiation and Protective Function of Cytolytic CD4 T Cells in Influenza Infection
Brown, D. M., Lampe, A. T., & Workman, A. M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00093 · Cited by 69
Porakishvili, N., Kardava, L., Jewell, A. P., Yong, K., Glennie, M. J., Akbar, A. N., & Lydyard, P. M. (2004) · PubMed · Cited by 67
Baumgaertner, P., Nunes, C. C., Cachot, A., Hajjami, H. M.-E., Cagnon, L., Braun, M., Derré, L., Rivals, J. P., Rimoldi, D., Gnjatic, S., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1216290 · Cited by 67
Self-citationIndividual Human Cytotoxic T Lymphocytes Exhibit Intraclonal Heterogeneity during Sustained Killing
de Vasconcelos, Z. F. M., Müller, S., Guipouy, D., Yu, W., Christophe, C., Gadat, S., Valitutti, S., & Dupré, L. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.05.002 · Cited by 61
Merouane, A., Rey-Villamizar, N., Lu, Y., Liadi, I., Romain, G., Lu, J., Singh, H., Cooper, L. J. N., Varadarajan, N., & Roysam, B. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv355 · Cited by 53
Yang, D., Tian, Z., Zhang, M., Yang, W.-B., Tang, J., Wu, Y., & Ni, B. (2017) · Scientific Reports · doi:10.1038/s41598-017-01379-y · Cited by 51
TCR-ligand dissociation rate is a robust and stable biomarker of CD8+ T cell potency
Allard, M., Couturaud, B., Carretero-Iglesia, L., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.92570 · Cited by 45
Munier, C. M. L., van Bockel, D. J., Bailey, M., Ip, S., Xu, Y., Alcântara, S., Liu, S. M., Denyer, G. S., Kaplan, W. H., Suzuki, K., et al. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.09.009 · Cited by 41
Burel, J. G., Apte, S. H., Groves, P., Klein, K., McCarthy, J. S., & Doolan, D. L. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005839 · Cited by 37
Histone deacetylases 1 and 2 restrain CD4+ cytotoxic T lymphocyte differentiation
Preglej, T., Hamminger, P., Luu, M., Bulat, T., Andersen, L., Göschl, L., Stolz, V., Rica, R., Sandner, L., Waltenberger, D., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.133393 · Cited by 36
Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells
Liadi, I., Roszik, J., Romain, G., Cooper, L. J. N., & Varadarajan, N. (2013) · Journal of Visualized Experiments · doi:10.3791/50058-v · Cited by 27
Cytotoxic CD4+ T-cells during HIV infection: Targets or weapons?
Sánchez-Martínez, A., Perdomo-Celis, F., Acevedo-Sáenz, L., Rugeles, M. T., & Velilla, P. A. (2019) · Journal of Clinical Virology · doi:10.1016/j.jcv.2019.08.004 · Cited by 25
Khazen, R., Müller, S., Lafouresse, F., Valitutti, S., & Cussat‐Blanc, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-48711-2 · Cited by 23
IL-12 Controls Cytotoxicity of a Novel Subset of Self-Antigen-Specific Human CD28+ Cytolytic T Cells
Barbey, C., Baumgaertner, P., Devêvre, E., Rubio‐Godoy, V., Derré, L., Bricard, G., Guillaume, P., Luescher, I. F., Líénard, D., Cerottini, J., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3566 · Cited by 17
Self-citationBroad and Conserved Immune Regulation by Genetically Heterogeneous Melanoma Cells
Neubert, N. J., Tillé, L., Barras, D., Soneson, C., Baumgaertner, P., Rimoldi, D., Gfeller, D., Delorenzi, M., Marraco, S. A. F., & Speiser, D. E. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2680 · Cited by 17
Self-citation
Cited by
Sun, L., Su, Y., Jiao, A., Wang, X., & Zhang, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01471-y · Cited by 1,014
Dynamics and specificities of T cells in cancer immunotherapy
Oliveira, G., & Wu, C. J. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-023-00560-y · Cited by 525
Speiser, D. E., Chijioke, O., Schaeuble, K., & Münz, C. (2023) · Nature Cancer · doi:10.1038/s43018-023-00521-2 · Cited by 479
Self-citationCytotoxic CD4+ T cells in cancer: Expanding the immune effector toolbox
Oh, D. Y., & Fong, L. (2021) · Immunity · doi:10.1016/j.immuni.2021.11.015 · Cited by 467
Baessler, A., & Vignali, D. A. A. (2024) · Annual Review of Immunology · doi:10.1146/annurev-immunol-090222-110914 · Cited by 420
Metadata
- Authors
- Cachot, A., Bilous, M., Liu, Y.-C., Li, X., Saillard, M., Cenerenti, M., Rockinger, G. A., Wyss, T., Guillaume, P., Schmidt, J., Genolet, R., Ercolano, G., Protti, M. P., Reith, W., Ioannidou, K., de Leval, L., Trapani, J. A., Coukos, G., Harari, A., Speiser, D. E., Mathis, A., Gfeller, D., Altug, H., Romero, P., & Jandus, C.
- Venue
- Science Advances
- Published
- 2021-02-26
- Volume
- 7
- Issue
- 9
- ISSN
- 2375-2548 (ISSN-L)
- OpenAlex
- W3130718611
- Cited by
- 328
- References
- 70
- FWCI
- 16.59
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.